The ASU team — led by Joshua LaBaer, executive director of the Biodesign Institute and director of the Center for Personalized Diagnostics, and co-principal investigator Vel Murugan — aims to develop a technology that will use a single drop of blood to quickly read a person’s epigenetic “fingerprint.†The fingerprint will identify signatures that indicate if the individual has ever been exposed to materials associated with producing weapons of mass destruction.
Be the first to comment